Atlas Trials

Effects of Pre-emptive Scalp Infiltration With Low-dose Ketorolac and Ropivacaine for Postoperative Pain

Clinical trial NCT04380298 · UNKNOWN

Trial details

NCT number
NCT04380298
Sponsor
Beijing Tiantan Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
PainSupratentorial Brain Tumor
Start date
2020-12-01
Primary completion
2021-07-31
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.